# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for ANDA 077446 on September 27, 2012, expanding its generic pharmaceutical portfolio and positioning the company to capture additional market share in the competitive generic drug sector. The approval strengthens Sandoz's ability to offer cost-effective therapeutic alternatives to healthcare providers and patients.